As it is impossible to differentiate these types of himophilia on clinical grounds the final diagnosis can only be made in the laboratory.
In 1955, in co-operation with the Medical Research Council, we carried out a survey of all possible hxmophilics in Northern Ireland. We began with a nucleus of patients already known to us. With the help of the Northern Ireland Hospitals Authority and Northern Ireland General Health Services Board, we were able to approach the great majority of family doctors and consultants in Northern Ireland, from whom we received every co-operation. Although no survey of this kind can claim to be complete, we believe it to represent the majority of the "bleeders" in Northern Ireland. We established a register of all hemophilics in this area and offered facilities for the treatment of bleeding episodes. In cooperation with the Dental Department of the Royal Victoria Hospital, we introduced a service for regular dental inspection and conservative treatment.
We feel that the information obtained during this survey and our subsequent experience in management are of sufficient general interest to warrant publication.
WHAT IS HAEMOPHILIA?
The older workers recognized this disorder by the presence of a classical triad which consisted of: (a) A persistent bleeding tendency in a male appearing in early life. While not all cases show the combination of typical clinical manifestations, characteristic hereditary pattern, or evidence of delayed blood-clotting, yet all have a deficiency in a blood-clotting factor. Nowadays the more modem laboratory tests have allowed the precise determination of the clotting factor responsible for this bleeding disorder. This has led to the discovery that cases of ha!mophilia with similar clinical and hereditary manifestations may have 11 different clottinig factor deficienicies. The factor which is deficient in classical haxmophilia is antihaemophilic factor. Biggs, et al. (1952) , described some cases of a haemophilic-like condition which was due, not to a deficiency in antihxmophilic factor, but to another factor also necessary for thromboplastin formation. This was called Christmas factor after the surname of the first patient in whom the defect was recognized. This factor is probably identical with plasma thromboplastin component deficiency described independently by Aggeler, et al. (1952) , in America. More recently Rosenthal, et al. (1953) Lee and White (1913) , which attempts to ensure that an equal area of water-wettable glass surface is exposed to the blood, provides more reliable and reproducible results. By this method normal blood should clot within ten minutes. Time. This test is normal in hxmophilics since the added tissue thromboplastin is able to convert prothrombin to thrombin in the presence of calcium and hence change the fibrinogen to fibrin.
P-rothrombin
The prothrombin test will detect deficiencies in prothrombin, factor V and factor VII, and thus separate these disorders from the hxmophilic states. It is, therefore, a useful screening test. The principle of the test is to measure in vitro the rate at which thromboplastin is generated by the blood of an individual. Any significant reduction in the amount of any of the coagulation factors will reduce the rate of thromboplastin generation. In our hands we have found the thromboplastin generation test a satisfactory way of diagnosing hamophilia. Usually a diagnosis of hxmophilia can be made without the use of blood from a known hamophilic patient.
However, in some mild cases we have had to use hoemophilic plasma in order to determine whether the plasma of the patient will correct the defect of a known hoemophilic patient.
5. I'he Antihbemophilic Factor Assayy.
The assay of the amount of antihxmophilic factor present in the plasma is of considerable value both in the diagnosis and in the management of hxmophilia. We have found the method of Pitney (1956) It is generally agreed that the incidence of hxmophilia is probably greater than most people believe. Since more extensive surveys have been carried out, the actual incidence has been found to be much greater than the hitherto accepted or known incidence in the area involved. In Northern Ireland the total number of "h2emophilics" so far discovered has been forty-three in a total and fairly stable population of 1.75 x 106. Of these, thirty-nine were cases of classical haemophilia givinig an incidence of 1 in 45,000 for this disease. This is comparable with the incidenice given by Biggs and Macfarlane (1954) 'CLINICAL FEATURES. The clinical features of hemophilia are well known and we have little to add to this aspect of the disease. As the condition is a hereditary defect, which results in a predisposition to bleed readily, it is not surprising that the onset frequently occurs in early life. In the majority of cases in our series the symptoms had been present since infancy, but in a few the presenting symptoms did not occur until adult life.
The bleeding tendency was episodic, varied in. severity, and had an undue frequency in the spring. It was not possible to elicit any precipitating factors, which would account satisfactorily for the clinical relapses. Mary patients showed a tendency to reproduce the same hxmorrhagic pattern; some bled mainly into joints, others into muscles, and others from the renal tract. However, a combination of hxmorrhagic manifestations also occurred.
Severity of the bleeding varied from case to case and was fairly well correlated with the antihemophilic factor level in the plasma. Mild cases were usually associated with an antihaemophilic factor level above 10 per cent. The bleeding in mild cases only followed surgical intervention or gross trauma. Five of our cases were of this type. The type of presentation in the remainder varied but the infrequency of epistaxis was notable. 14 CORRELATION BETWEEN CLINICAL SEVERITY AND LABORATORY TESTS. The correlation between the degree of clinical severity and the laboratory tests used in diagnosis do not always show a very satisfactory relationship. The tests which we will consider are the whole blood clotting time, the serum prothrombin activity, and the antilixmophilic factor level. 1. Clotting Time.
It is well known that this test is unsatisfactory as a diagnostic laboratory method in view of the fact that many hxmophilics have a normal clotting time (Fig. 1) It would seem logical that the degree of the deficiency of the specific clotting factor in the blood would correlate with the severity of the clinical manifestations. In general, this has been found to be the case.
Since the introduction of the quantitative assay method it has been shown that mild cases usually have an antihaemophilic factor level above 10 per cent., and severely affected cases a level below 5 per cent. The levels of antihaemophilic factor in seventeen of our patients are shown in Table 3 correlated with the clinical grades of severity of the disease. (Merskey, 1951; Israels, et al., 1951) . In hemophilic dogs the mating of female carriers to male haemophilic animals has produced haemophilic female dogs (Brinkhous and Graham, 1950) . Figure 2 shows the idealised pattern of haemophilic inheritance.
In conjunctioni with the Department of Social Medicine we have investigated all the families of patients suffering from hamophilia in Northern Ireland. It has been found that the family histories do not always reveal a bleeder on the maternal side. We have obtained a positive family history in 45 per cent. of our cases and in the remainder the disease appears to be sporadic. The sporadic cases may be due to non-recognition of the disease in the forebears or to spontaneous gene mutation. These findings are in conformity with those of other observers (Biggs and Macfarlane, 1958 There is as yet no reliable way of recognising the female carrier. In our series six mothers of haemophilic children were tested and in two a defect in antihoemophilic factor was demonstrated. Their alumina-absorbed plasma, when tested in a normal system, produced normal thromboplastin generation but failed to correct the abnormal generation of known haemophilic plasma. This is to say, of six female haemophilic carriers two had a partial antihanmophilic factor defect. Similar results have been obtained in haemophilic carriers by Pitney (1958) .
GENERAL MANAGEMENT.
As these patients are subject to repeated episodes of severe haemorrhage they need to be admitted to hospital on numerous occasions. Many of these admissions are emergencies which require special management. There is, therefore, much to be said for the establishment of special centres for these patients, as has been organised in association with the Medical Research Council. Since haemophilia is a chronic, and in its severe form, a very disabling disease, every effort is needed to sustain morale and develop a healthy psychological approach to this life-long disorder.
It is not proposed to deal with all aspects of treatment but only with the treatment of a bleeding episode. Our experience in the management of dental extraction will be the subject of a separate communication.
TREATMENT OF A BLEEDING EPISODE IN CLASSICAL HJEMOPHILIA.
There have in the past been many claims put forward in support of non-plasma preparations for treatment but none have been substantiated. The only effective therapeutic preparations are fresh whole blood, fresh plasma or some specially processed fresh plasma. It is preferable to use plasma of human origin because of its relative freedom from antigenic properties. Although animal plasma is high in antihamophilic factor content it is strongly antigenic and consequently its use is restricted. Animal plasma has been successfully employed to tide a patient over an acute episode. Our experience has been mainly confined to the use of fresh human plasma either used immediately or stored at -20°C. for not more than ten days and then allowed to thaw at room temperature prior to transfusion. We have also used the dried human plasma processed according to the technique of Kekwick and Wolf (1957) and kindly made available to us by Dr. Maycock of the Lister Institute. We have found it to be therapeutically equivalent to the volume of fresh wet plasma from which it was prepared.
The response to therapy with wet and concentrated plasma are shown in Table 4 . It vill be seen from this that the antihxmophilic factor rise per 100 nil. was comparable in both cases. However, the concentrated preparation has the advantage of being contained in a smaller volume.
In the past the control of hamorrhage was frequently ineffective due to inadequate dosage. The object of plasma therapy is to raise the antihaemophilic factor content of the blood of the patient to a hxmostatic level and to maintain this level until bleeding is controlled. To achieve the first objective it is necessary to have some understanding of the antihamophilic factor content in fresh and stored plasma, the hemostatic level of antihaemophilic factor required and the dose of plasma needed to reach this level. To achieve the second objective some information on the survival of transfused antihamophilic factor in the circulation is needed.
It is well known that the antihxmophilic factor is labile and therefore its concentration dimiinishes on storage. The factors which influence the rate of destruction are not fully understood, but there is some evidence to suggest that minor clot formation in the stored blood utilises antihamophilic factor and therefore reduces the amount available for therapeutic use. To achieve the maximum yield of antihoemophilic factor, care in the details of collection, separation, and storage are important. There is great variation in the levels of antihrmophilic factor among normal individuals. The antihamophilic factor concentrations in normal plasmas may vary from about 50 to 170 per cent. of the mean (Langdell, et al., 1953) . The antihaemophilic factor level of a given person appears to be relatively constant.
Brinkhous (1956) reported the results found in the study of antihamophilic factor remaining in stored whole blood at 40 C., frozen plasma at -200 C. and lyophilized plasma. From these results he concluded that after two weeks' storage whole blood retained over 50 per cent. of its initial antihaemophilic factor, whereas after three weeks only very small amounts of antihoemophilic factor remained. The deterioration in fresh frozen plasma was similar over the first two weeks but the content then remained fairly stable. In a sample tested after eighteen weeks, half of its initial activity remained. Brinkhous considers that the antihamophilic factor content of fresh frozen plasma is approximately that of the lower limits of the normal range in an adult.
To control bleeding, Biggs considers that an antihxmophilic factor level of 30 per cent. is required. This is not always easv to achieve. Langdell, Wagner, and Brinkhous (1955) suggested that an antihomophilic factor concentration consistently maintained above 5 per cent. will control haemorrhage in many instances and this has been our experience (Fig. 3) . In an individual with a normal blood volume, 1,500 ml. of plasma would be required to achieve a 30 per cent. level of antihomophilic factor or 500 ml. to raise the antihaemophilic factor to 10 per cent. In practice we give a 1,000 ml. priming dose. It is important to reach the hxmostatic level quickly, so this is given in 15-30 minutes under careful supervision. We have not produced any circulatory overload with this procedure. The maintenance of a hxmostatic level depends on the loss of antihamophilic factor due to tissue hamorrhage and to decay arising from the short survival time in the circulation of the transfused antihxmophilic factor. Aggeler (1956) has shown that the half-life of antihemophilic factor in the hoemophilic is probably less than twelve hours. However, Brinkhous, et al. (1956) , consider that the half-life is about four hours. In the one patient in whom this was studied we found an approximate half-life of twelve hours. Because of the difficulty in determining the maintenance dose of plasma required, we have been content to use intermittent plasma therapy for our patients. We have found that the clinical hemostatic effect of a plasma transfusion lasts twenty-four hours. Consequently we have transfused these patients at 24 or sometimes at 48-hour intervals until bleeding is controlled. 20
Apart from systemic therapy, all ordinary surgical precautions must be observed. Christmas factor is more stable than antihxmophilic factor. As it is not used during coagulation, it is found in blood serum. Furthermore, it is claimed that Christmas factor, when transfused into a patient, has a long half-life and may remain in the circulation for two to three weeks (Beaumont, et al., 1954 A survev has been made of hamophilia in Northern Ireland. Thirty-nine cases of classical hxmophilia have been found in the population in this area, giving an incidence of one in 45,000. A study of the hereditary pattern has revealed a positive family history in 45 per cent. of our cases.
The value of laboratory tests in the diagnosis of ha!mophilia was studied. On the tests used the clotting time was found to be least valuable, being normal in one-third of the cases. The serum prothrombin activity was a more useful diagnostic test but the most valuable was the thromboplastin generation test. A modification of this test allows a quantitative estimation of the antihaemophilic factor in the plasma to be made.
The clinical severity of the cases was found to correlate with the level of antihaemophilic factor in the plasma. Mild cases had a level above 10 per cent. and severe cases a level below 5 per cent. 22
The management of bleeding episodes in classical hxmophilia is described.
The importance of rapid and adequate plasma transfusion to attain a haemostatic level of antihoemophilic factor is stressed. Four cases of Christmas disease have also been studied and a positive family history obtained in three of these. The hereditary pattern and clinical manifestations were identical with classical haemophilia. Differential diagnosis can only be established using the thromboplastin generation test. The management of bleedinig episodes in Christmas disease is described. The relative ease in controlling haemorrhage, even with small plasma transfusions, is pointed out. Christmas disease can also be successfully treated by transfusion of serum. Because of this it is important to establish an accurate diagnosis between these two conditions before therapy is applied.
